CheekAge-Test, entwickelt von Tally Health, schätzt das Mortalitätsrisiko durch DNA-Methylierung und übertrifft Bluttests. CheekAge test, developed by Tally Health, estimates mortality risk through DNA methylation, outperforming blood-based tests.